Clearbridge Investments LLC Sells 210,841 Shares of Corteva, Inc. $CTVA

Clearbridge Investments LLC reduced its stake in Corteva, Inc. (NYSE:CTVA) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,645,042 shares of the company’s stock after selling 210,841 shares during the period. Clearbridge Investments LLC owned 0.24% of Corteva worth $110,267,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CTVA. JPL Wealth Management LLC bought a new stake in Corteva in the third quarter valued at $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva in the third quarter valued at $29,000. Jackson Grant Investment Advisers Inc. increased its stake in Corteva by 90.6% in the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. Basepoint Wealth LLC bought a new stake in Corteva in the fourth quarter valued at $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new stake in Corteva in the third quarter valued at $33,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Down 1.3%

Corteva stock opened at $76.04 on Tuesday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The stock has a market cap of $50.86 billion, a PE ratio of 44.73, a price-to-earnings-growth ratio of 2.36 and a beta of 0.57. The firm’s 50-day simple moving average is $81.03 and its 200 day simple moving average is $75.09. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the previous year, the company earned $1.13 earnings per share. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

Analyst Ratings Changes

CTVA has been the subject of several recent research reports. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Mizuho boosted their target price on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Argus boosted their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Finally, The Goldman Sachs Group boosted their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and an average price target of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.